Skip to main content

Want a detailed portfolio tracker?

Pulmatrix (PULM) P/E (2015 - 2026)

Pulmatrix (PULM) P/E from Jun 30, 2015 to Jul 21, 2026. The TTM Pulmatrix (PULM) P/E is -1.37. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pulmatrix (PULM)

YearP/EChange
2026-1.37-13.00%
2025-1.58-40.92%
2024-2.67+538.87%
2023-0.42-40.89%
2022-0.71-43.63%
2021-1.25-30.42%
2020-1.80+197.68%
2019-0.60-8.34%
2018-0.66-81.76%
2017-3.62+273.33%
2016-0.97-84.68%
2015-6.33N/A

Comparison Pulmatrix (PULM) P/E with competitors

Pulmatrix (PULM) P/E is -1.37.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.00-100.31%
ENLVEnlivex Ltd0.07-105.46%
FGENFibroGen Inc0.24-117.51%
CHRSCoherus Biosciences Inc0.85-161.91%
FBIOFortress Biotech Inc0.95-169.24%
ORMPOramed Pharmaceuticals Inc1.50-209.66%
AGENAgenus Inc3.01-319.57%
INVAInnoviva Inc3.15-330.11%
VXRTVaxart Inc3.55-358.98%
CRMDCorMedix Inc3.63-364.72%
CVACCureVac N.V.4.45-424.34%
GLPGGalapagos NV4.86-454.49%
SRPTSarepta Therapeutics Inc4.88-456.18%
ABEOAbeona Therapeutics Inc5.39-493.06%
ABUSArbutus Biopharma Corp5.60-508.24%
ZVRAZevra Therapeutics Inc5.89-529.52%
SPROSpero Therapeutics Inc6.23-554.41%
CGENCompugen Ltd6.31-560.65%
RIGLRigel Pharmaceuticals6.87-601.37%
SLXNSilexion Therapeutics Corp7.30-632.30%
OMEROmeros Corporation9.26-775.49%
AUPHAurinia Pharmaceuticals Inc9.58-799.29%
PLXProtalix BioTherapeutics Inc10.89-894.58%
ACADAcadia Pharmaceuticals Inc11.73-955.68%
TBPHTheravance Biopharma Inc12.26-994.61%
ADMAAdma Biologics Inc12.42-1005.99%
HRMYHarmony Biosciences Holdings Inc13.82-1108.28%
SABSSAB Biotherapeutics Inc14.14-1131.34%
NAGENiagen Bioscience Inc14.82-1181.09%
INCYIncyte Corp15.82-1254.37%
REGNRegeneron Pharmaceuticals Inc15.86-1256.86%
PBYIPuma Biotechnology Inc17.32-1363.31%
CPRXCatalyst Pharmaceuticals Inc17.44-1372.33%
EXELExelixis Inc17.54-1379.53%
TGTXTG Therapeutics Inc18.97-1483.71%
MDXGMimedx Group Inc20.55-1599.46%
XOMAXOMA Royalty Corp22.87-1768.92%
ARGXArgen X SE24.30-1872.77%
CTMXCytomX Therapeutics Inc24.82-1910.93%
XOMAOXOMA Royalty Corp25.34-1949.14%
HALOHalozyme Therapeutics Inc25.62-1969.49%
XOMAPXOMA Royalty Corp25.67-1972.88%
VRTXVertex Pharmaceuticals Inc27.99-2142.48%
RPRXRoyalty Pharma plc - Class A28.69-2193.02%
SLNOSoleno Therapeutics Inc29.02-2216.94%
ASNDAscendis Pharma A/S30.09-2295.02%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2866.04%
APLSApellis Pharmaceuticals Inc39.02-2946.96%
BMRNBiomarin Pharmaceutical Inc42.21-3179.75%
KRYSKrystal Biotech Inc45.34-3408.23%
ONCBeiGene Ltd69.54-5173.63%
PHARPharming Group N.V.75.03-5573.82%
TECHBio-Techne Corp101.96-7538.82%
VCELVericel Corp109.92-8119.80%
ALNYAlnylam Pharmaceuticals Inc117.96-8706.66%
GMABGenmab140.29-10335.53%
TLXTelix Pharmaceuticals Ltd162.15-11930.58%
CORTCorcept Therapeutics Inc212.86-15629.96%